Icaritin
SIGMA/SML0551 - ≥98% (HPLC)
Synonym: 3,5,7-
CAS Number: 118525-40-9
Empirical Formula (Hill Notation): C21H20O6
Molecular Weight: 368.38
MDL Number: MFCD22422519
Linear Formula: C21H20O6
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | light yellow to dark yellow |
| form | powder |
| InChI | 1S/C21H20O6/c1-11(2)4-9-1 |
| InChI key | TUUXBSASAQJECY-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | COc1ccc(cc1)C2=C(O)C(=O)c |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Icaritin enhances osteoblastic differentiation of mesenchymal stem cells (MSCs) while it inhibits adipogenic differentiation of MSCs. |
| Biochem/physiol Actions: | Icaritin enhances osteoblastic differentiation of mesenchymal stem cells (MSCs). It may have estrogen-like activities. |
| Biochem/physiol Actions: | Icaritin is a component of Epimedium flavonoid isolated from Herba Epimedii, which enhances osteoblastic differentiation of mesenchymal stem cells (MSCs) while it inhibits adipogenic differentiation of MSCs by inhibiting PPAR-g pathway. Icaritin has no effect on MSCs proliferation. Also, icaritin potently inhibits chronic myeloid leukemia (CML) and breast cancer cells proliferation most likely by modulation of MAPK/ERK/JNK and JAK2/STAT3 /AKT signaling. As other flavonoids, icaritin may exert estrogen-like activities. |
| Features and Benefits: | This compound is featured on the JAKs , MAPKs and Nuclear Receptors (PPARs) pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

